3
Shared Docs
3
Same-Page
4 / 3
Mentions
. It was classic self-dealing. The drug in question was meant to treat multiple sclerosis. It failed in clinical trials in 2017 and prosecutors say Collins illegally spread the word to family and others who were able to sell their stock before its price collapsed on the bad news. Collins has pleaded no
Page: EFTA00018482 →0, U.S. District Court, Southern District of New York (Manhattan). 16 EFTA00018481 --- PAGE BREAK --- SDNY News Clips, Wednesday, July 31, 2019 Collins Editorial: Failures of ethics Buffalo News By News Editorial Board 7/29/19 The ethics specialists are right and so are the members of a special
Page: EFTA00018482 →no conflict because Innate had no business before U.S. regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have ben
Page: EFTA00018482 →v. Epstein, 19-cr-490, U.S. District Court, Southern District of New York (Manhattan). 16 EFTA00069941 SDNY News Clips, Wednesday, July 31, 2019 Collins Editorial: Failures of ethics Buffalo News By News Editorial Board 7/29/19 The ethics specialists are right and so are the members of a special
no conflict because Innate had no business before U.S. regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have ben
12 PM Cc: Subject: SDNY News Clips Wednesday, July 31, 2019 SDNY News Clips Wednesday, July 31, 2019 Contents Public Corruption. 2 Epstein. 2 Collins. 18 Securities and Commodities Fraud. 20 Stewart 20 Thompson. 22 Pinto-Thomaz. 24 Narcotics. 26 Castro. 26 Rochester Drug Company. 28 Civil 3
no conflict because Innate had no business before U.S. regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have ben
Entities connected to both Collins and the U.S. Food and Drug Administration

Jeffrey Epstein
PERSON
Donald Trump
PERSON
United States
LOCATION
Department of Justice
ORGANIZATION
Prince Andrew
PERSON
Ghislaine Maxwell
PERSON
Julie K. Brown
PERSONLeon Black
PERSON
Joe Biden
PERSONEmmy Taylor
PERSON
Bloomberg L.P.
ORGANIZATION
Scarlett Johansson
PERSON
Virginia Giuffre
PERSON
Stephen Hawking
PERSON
New York
LOCATION
USA Today
ORGANIZATION
George Mitchell
PERSON
Barack Obama
PERSON
Axios
ORGANIZATION
William Barr
PERSON